Kevin Mccallion Sells 5,420 Shares of 908 Devices (NASDAQ:MASS) Stock

Key Points

• Insider sale: SVP Kevin McCallion sold 5,420 shares on April 9 at an average price of $7.03 under a pre-arranged Rule 10b5-1 plan, reducing his stake by 10.77% (transaction value ~$38,103) and leaving him with 44,925 shares.
• Recent results and stock stats: MASS traded around $7.14 (50-day SMA $6.47, 200-day SMA $6.67), has a market cap of ~$267M and a PE of 12.98; the latest quarter beat revenue and EPS estimates with $17.38M in revenue and EPS of ($0.05) vs. ($0.06) expected.
• Ownership and outlook: Institutional investors own about 88.06% of the company, analyst sentiment is mixed (one Buy, one Sell) with an average rating of "Hold" and an average target price of $12.00.

908 Devices Inc. (NASDAQ:MASS - Get Free Report) SVP Kevin Mccallion sold 5,420 shares of the firm's stock in a transaction dated Thursday, April 9th. The stock was sold at an average price of $7.03, for a total transaction of $38,102.60. Following the completion of the sale, the senior vice president owned 44,925 shares of the company's stock, valued at $315,822.75. This trade represents a 10.77% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

908 Devices Price Performance

Shares of 908 Devices stock traded up $0.18 during trading on Friday, hitting $7.14. The stock had a trading volume of 244,540 shares, compared to its average volume of 254,609. The firm's fifty day simple moving average is $6.47 and its 200-day simple moving average is $6.67. The stock has a market cap of $266.89 million, a PE ratio of 12.98 and a beta of 0.54. 908 Devices Inc. has a 12 month low of $3.79 and a 12 month high of $9.34.

908 Devices (NASDAQ:MASS - Get Free Report) last announced its quarterly earnings data on Tuesday, March 3rd. The company reported ($0.05) earnings per share for the quarter, beating analysts' consensus estimates of ($0.06) by $0.01. 908 Devices had a net margin of 34.68% and a negative return on equity of 14.99%. The company had revenue of $17.38 million during the quarter, compared to analyst estimates of $16.19 million. Analysts expect that 908 Devices Inc. will post -1.99 earnings per share for the current fiscal year.

Institutional Investors Weigh In On 908 Devices

Several large investors have recently modified their holdings of the business. Rhumbline Advisers grew its position in shares of 908 Devices by 5.5% in the 2nd quarter. Rhumbline Advisers now owns 36,416 shares of the company's stock worth $260,000 after buying an additional 1,894 shares during the last quarter. Graham Capital Management L.P. grew its position in 908 Devices by 12.9% during the 4th quarter. Graham Capital Management L.P. now owns 20,787 shares of the company's stock worth $109,000 after purchasing an additional 2,374 shares during the last quarter. Farther Finance Advisors LLC acquired a new stake in 908 Devices during the 3rd quarter valued at approximately $28,000. Cresset Asset Management LLC lifted its stake in 908 Devices by 37.1% during the 3rd quarter. Cresset Asset Management LLC now owns 16,100 shares of the company's stock valued at $141,000 after acquiring an additional 4,355 shares during the period. Finally, Barclays PLC lifted its stake in 908 Devices by 15.4% during the 4th quarter. Barclays PLC now owns 44,528 shares of the company's stock valued at $234,000 after acquiring an additional 5,943 shares during the period. Institutional investors own 88.06% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on MASS shares. Weiss Ratings reiterated a "sell (d-)" rating on shares of 908 Devices in a report on Wednesday, January 21st. Wall Street Zen upgraded shares of 908 Devices from a "hold" rating to a "buy" rating in a report on Saturday, March 14th. One research analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of "Hold" and an average target price of $12.00.

908 Devices Company Profile

908 Devices Inc NASDAQ: MASS is a developer and manufacturer of portable analytical instruments designed to deliver rapid chemical detection in field and laboratory environments. The company's core focus lies in miniaturizing high-performance mass spectrometry and ion mobility spectrometry technologies, enabling users to perform on-site analysis that traditionally required benchtop equipment.

Key products in 908 Devices' portfolio include the MX908, a handheld high-resolution mass spectrometer capable of detecting and identifying a broad range of chemicals and explosives; the M908 portable mass spectrometer for laboratory or mobile units; and the ZipChip capillary electrophoresis system for high-throughput, microfluidic separations.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.